1,2,4-OXADIAZOLE DERIVATIVES AS LIVER X RECEPTOR AGONISTS
Provided herein are compounds and pharmaceutical compositions useful for treating meibomian gland dysfunction (MGD), comprising administering to a subject in need thereof a therapeutically effective amount of a compound of Formula (I) or a compound of Formula (I'), or pharmaceutical composition...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; spa |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | SMITH, Jeffrey LINKENS, Kathryn Taylor SHAW, Duncan FLYER, Alec Nathanson HARDY, Declan MA, Fupeng LOREN, Jon Christopher BOSS, Kelly D FAN, Yi MOLTENI, Valentina SOLOVAY, Catherine Fooks HUANG, Zhihong |
description | Provided herein are compounds and pharmaceutical compositions useful for treating meibomian gland dysfunction (MGD), comprising administering to a subject in need thereof a therapeutically effective amount of a compound of Formula (I) or a compound of Formula (I'), or pharmaceutical composition described herein.
Se proporcionan aquí compuestos y composiciones farmacéuticas útiles para el tratamiento de la disfunción de la glándula de Meibomio (MGD), que comprende administrar a un sujeto que lo necesita una cantidad terapéuticamente eficaz de un compuesto de Fórmula (I) o un compuesto de Fórmula (I'), o una composición farmacéutica descripta en la presente memoria. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CR20220227A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CR20220227A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CR20220227A3</originalsourceid><addsrcrecordid>eNrjZLA01DHSMdH1j3B08XSM8vdxVXBxDfIMcwzxDHMNVnAMVvABMoIUIhSCXJ1dA0L8gxQc3f39PINDgnkYWNMSc4pTeaE0N4OCm2uIs4duakF-fGpxQWJyal5qSbxzkJGBEQiZOxoToQQACYgn9A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>1,2,4-OXADIAZOLE DERIVATIVES AS LIVER X RECEPTOR AGONISTS</title><source>esp@cenet</source><creator>SMITH, Jeffrey ; LINKENS, Kathryn Taylor ; SHAW, Duncan ; FLYER, Alec Nathanson ; HARDY, Declan ; MA, Fupeng ; LOREN, Jon Christopher ; BOSS, Kelly D ; FAN, Yi ; MOLTENI, Valentina ; SOLOVAY, Catherine Fooks ; HUANG, Zhihong</creator><creatorcontrib>SMITH, Jeffrey ; LINKENS, Kathryn Taylor ; SHAW, Duncan ; FLYER, Alec Nathanson ; HARDY, Declan ; MA, Fupeng ; LOREN, Jon Christopher ; BOSS, Kelly D ; FAN, Yi ; MOLTENI, Valentina ; SOLOVAY, Catherine Fooks ; HUANG, Zhihong</creatorcontrib><description>Provided herein are compounds and pharmaceutical compositions useful for treating meibomian gland dysfunction (MGD), comprising administering to a subject in need thereof a therapeutically effective amount of a compound of Formula (I) or a compound of Formula (I'), or pharmaceutical composition described herein.
Se proporcionan aquí compuestos y composiciones farmacéuticas útiles para el tratamiento de la disfunción de la glándula de Meibomio (MGD), que comprende administrar a un sujeto que lo necesita una cantidad terapéuticamente eficaz de un compuesto de Fórmula (I) o un compuesto de Fórmula (I'), o una composición farmacéutica descripta en la presente memoria.</description><language>eng ; spa</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220615&DB=EPODOC&CC=CR&NR=20220227A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76552</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220615&DB=EPODOC&CC=CR&NR=20220227A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SMITH, Jeffrey</creatorcontrib><creatorcontrib>LINKENS, Kathryn Taylor</creatorcontrib><creatorcontrib>SHAW, Duncan</creatorcontrib><creatorcontrib>FLYER, Alec Nathanson</creatorcontrib><creatorcontrib>HARDY, Declan</creatorcontrib><creatorcontrib>MA, Fupeng</creatorcontrib><creatorcontrib>LOREN, Jon Christopher</creatorcontrib><creatorcontrib>BOSS, Kelly D</creatorcontrib><creatorcontrib>FAN, Yi</creatorcontrib><creatorcontrib>MOLTENI, Valentina</creatorcontrib><creatorcontrib>SOLOVAY, Catherine Fooks</creatorcontrib><creatorcontrib>HUANG, Zhihong</creatorcontrib><title>1,2,4-OXADIAZOLE DERIVATIVES AS LIVER X RECEPTOR AGONISTS</title><description>Provided herein are compounds and pharmaceutical compositions useful for treating meibomian gland dysfunction (MGD), comprising administering to a subject in need thereof a therapeutically effective amount of a compound of Formula (I) or a compound of Formula (I'), or pharmaceutical composition described herein.
Se proporcionan aquí compuestos y composiciones farmacéuticas útiles para el tratamiento de la disfunción de la glándula de Meibomio (MGD), que comprende administrar a un sujeto que lo necesita una cantidad terapéuticamente eficaz de un compuesto de Fórmula (I) o un compuesto de Fórmula (I'), o una composición farmacéutica descripta en la presente memoria.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLA01DHSMdH1j3B08XSM8vdxVXBxDfIMcwzxDHMNVnAMVvABMoIUIhSCXJ1dA0L8gxQc3f39PINDgnkYWNMSc4pTeaE0N4OCm2uIs4duakF-fGpxQWJyal5qSbxzkJGBEQiZOxoToQQACYgn9A</recordid><startdate>20220615</startdate><enddate>20220615</enddate><creator>SMITH, Jeffrey</creator><creator>LINKENS, Kathryn Taylor</creator><creator>SHAW, Duncan</creator><creator>FLYER, Alec Nathanson</creator><creator>HARDY, Declan</creator><creator>MA, Fupeng</creator><creator>LOREN, Jon Christopher</creator><creator>BOSS, Kelly D</creator><creator>FAN, Yi</creator><creator>MOLTENI, Valentina</creator><creator>SOLOVAY, Catherine Fooks</creator><creator>HUANG, Zhihong</creator><scope>EVB</scope></search><sort><creationdate>20220615</creationdate><title>1,2,4-OXADIAZOLE DERIVATIVES AS LIVER X RECEPTOR AGONISTS</title><author>SMITH, Jeffrey ; LINKENS, Kathryn Taylor ; SHAW, Duncan ; FLYER, Alec Nathanson ; HARDY, Declan ; MA, Fupeng ; LOREN, Jon Christopher ; BOSS, Kelly D ; FAN, Yi ; MOLTENI, Valentina ; SOLOVAY, Catherine Fooks ; HUANG, Zhihong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CR20220227A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; spa</language><creationdate>2022</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>SMITH, Jeffrey</creatorcontrib><creatorcontrib>LINKENS, Kathryn Taylor</creatorcontrib><creatorcontrib>SHAW, Duncan</creatorcontrib><creatorcontrib>FLYER, Alec Nathanson</creatorcontrib><creatorcontrib>HARDY, Declan</creatorcontrib><creatorcontrib>MA, Fupeng</creatorcontrib><creatorcontrib>LOREN, Jon Christopher</creatorcontrib><creatorcontrib>BOSS, Kelly D</creatorcontrib><creatorcontrib>FAN, Yi</creatorcontrib><creatorcontrib>MOLTENI, Valentina</creatorcontrib><creatorcontrib>SOLOVAY, Catherine Fooks</creatorcontrib><creatorcontrib>HUANG, Zhihong</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SMITH, Jeffrey</au><au>LINKENS, Kathryn Taylor</au><au>SHAW, Duncan</au><au>FLYER, Alec Nathanson</au><au>HARDY, Declan</au><au>MA, Fupeng</au><au>LOREN, Jon Christopher</au><au>BOSS, Kelly D</au><au>FAN, Yi</au><au>MOLTENI, Valentina</au><au>SOLOVAY, Catherine Fooks</au><au>HUANG, Zhihong</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>1,2,4-OXADIAZOLE DERIVATIVES AS LIVER X RECEPTOR AGONISTS</title><date>2022-06-15</date><risdate>2022</risdate><abstract>Provided herein are compounds and pharmaceutical compositions useful for treating meibomian gland dysfunction (MGD), comprising administering to a subject in need thereof a therapeutically effective amount of a compound of Formula (I) or a compound of Formula (I'), or pharmaceutical composition described herein.
Se proporcionan aquí compuestos y composiciones farmacéuticas útiles para el tratamiento de la disfunción de la glándula de Meibomio (MGD), que comprende administrar a un sujeto que lo necesita una cantidad terapéuticamente eficaz de un compuesto de Fórmula (I) o un compuesto de Fórmula (I'), o una composición farmacéutica descripta en la presente memoria.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; spa |
recordid | cdi_epo_espacenet_CR20220227A |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | 1,2,4-OXADIAZOLE DERIVATIVES AS LIVER X RECEPTOR AGONISTS |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-16T01%3A50%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SMITH,%20Jeffrey&rft.date=2022-06-15&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECR20220227A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |